Table 2.

Mean ± SD for MMO in patients receiving prednisolone or celecoxib after surgical removal of impacted mandibular third molars in four measuring times

Groups	MMO
	Before surgery	24 h	48 h	168 h
Celecoxib	44.5 ± 6.9	30.4 ± 7.3	34.3 ± 7.3	42.5 ± 7.5
Prednisolone	46.6 ± 7.7	31.1 ± 10.3	33.2 ± 9.9	42.3 ± 8.9
p Value	NS	NS	NS	NS

MMO maximum mouth opening, NS not significant